Related Experiment Video
Updated: Jun 6, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
Abstract:
The P2X7 receptor (P2X7R) has been implicated in the process of multinucleation and cell fusion. We have previously demonstrated that blockade of P2X7Rs on osteoclast precursors using a blocking antibody inhibited multinucleated osteoclast formation in vitro, but that P2X7R KO mice maintain the ability to form multinucleated osteoclasts. This apparent contradiction of the role the P2X7R plays in multinucleation has prompted us to examine the effect of the most commonly used and recently available P2X7R antagonists on osteoclast formation and function. When added to recombinant RANKL and M-CSF human blood monocytes cultures, all but one compound, decreased the formation and function of multinucleated TRAP-positive osteoclasts in a concentration-dependent manner. These data provide further evidence for the role of the P2X7R in the formation of functional human multinucleated osteoclasts and highlight the importance of selection of antagonists for use in long-term experiments.
Insights
The P2X7 receptor (P2X7R) is crucial for forming multinucleated osteoclasts. P2X7R antagonists effectively inhibit osteoclast formation and function in human monocytes, underscoring the need for careful drug selection.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- The P2X7 receptor (P2X7R) is involved in cell fusion and multinucleation.
- Previous studies showed conflicting results regarding P2X7R's role in osteoclast formation.
Purpose of the Study:
- To investigate the effect of P2X7R antagonists on human osteoclast formation and function.
- To resolve discrepancies in the literature concerning P2X7R's role in multinucleation.
Main Methods:
- Human blood monocytes were cultured with RANKL and M-CSF.
- Various P2X7R antagonists were added to assess their impact on osteoclastogenesis.
- Multinucleated TRAP-positive osteoclasts were quantified and their function evaluated.
Main Results:
- Most P2X7R antagonists significantly decreased the formation and function of multinucleated osteoclasts in a dose-dependent manner.
- One antagonist showed no inhibitory effect, suggesting differential mechanisms or specificities.
- These findings confirm P2X7R's role in generating functional human osteoclasts.
Conclusions:
- The P2X7 receptor plays a significant role in the formation of functional human multinucleated osteoclasts.
- The choice of P2X7R antagonist is critical for experimental outcomes, especially in long-term studies.
- Further research is needed to understand the differential effects of various antagonists.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
